Being an Acute Care PNP Student During the COVID-19 Pandemic

INTerpath-009 investigates the treatment for patients with resectable stage 2, 3A or 3B non–small cell lung cancer.

Study shows intramuscular injection may improve treatment success by increasing the speed of drug absorption.

For individuals with normal blood pressure, a sudden drop in blood pressure can be dangerous because it creates a lack of critical oxygen.

This drug is the first to control complement factor C5a, which is a protein that plays a significant but potentially harmful role in the body's immune response.

Rezafungin (Rezzayo; Cidara Therapeutics Inc, Melinta Therapeutics LLC) is the first new treatment option approved for individuals with candidemia and invasive candidiasis in more than a decade.

Findings from the AFFIRM trial found increased risks after stopping oral anticoagulant therapy after rhythm control, and the same is true for stopping treatment with oral anticoagulants after successful ablation.